Summaries for patients. The cost-effectiveness of strategies to prevent type 2 diabetes.
D000328:Adult; D000368:Aged; D003198:Computer Simulation; D003362:Cost-Benefit Analysis; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000191:economics* / Q000517:prevention & control*; D004038:Diet, Reducing; D018450:Disease Progression; D015444:Exercise; D018149:Glucose Intolerance / Q000150:complications* / Q000191:economics; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics* / Q000627:therapeutic use; D008019:Life Style; D008390:Markov Chains; D008687:Metformin / Q000191:economics* / Q000627:therapeutic use; D008875:Middle Aged; D019057:Quality-Adjusted Life Years; D012680:Sensitivity and Specificity
D007004:Hypoglycemic Agents; D008687:Metformin